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Lindsay J. Buck
Whittier College

The Importance of Early
Intervention: Treatments for
Conduct Disorder versus
Treatments for Antisocial
Personality Disorder

This literature review focuses on both medicinal and therapeutic treatment
options for Conduct Disorder and Antisocial Personality Disorder. Conduct
Disorder is considered a precursor to Antisocial Personality Disorder, and
research on the treatment of both of these disorders suggests that early
intervention, during childhood and adolescence, is the most promising treatment
option for people diagnosed with Conduct Disorder. Medicinal treatments for
Conduct Disorder that are discussed within this literature review are lithium,
methylphenidate, and risperidone, while the therapeutic treatments reviewed are
parent management training and cognitive-behavioral therapy. Less encouraging
research results have been found for the treatment ofAntisocial Personality
Disorder, but this review will discuss risperidone and quetiapine as researched
medicinal treatments and residential treatment facilities as a therapeutic
treatment for the disorder. In all areas of treatment research, further studies are
needed to determine treatment efficacy.

Conduct Disorder (CD) and Antisocial Personality
Disorder (APD). The reason for exploring these
disorders together is that CD is viewed as an
antecedent to APD, and therefore timing of
treatment becomes a factor while considering
treatment options. Before delving into specific
treatments for these two disorders though, it is
necessary to familiarize one with the actual disorders
and their symptoms, since treatments typically aim to
reduce disorder symptomology. For purposes of
clarity and comprehension, the disorders will be

The DSM-IV TR (2000), published by the
American Psychiatric Association, is a widelyrecognized source used by mental health
professionals to classify mental disorders. Created
for diagnostic purposes, it includes descriptions of
each disorder categorized under the headings of
Diagnostic Features, Associated Features and
Disorders, Prevalence, and Differential Diagnosis. In
consulting the manual, it becomes readily apparent
that one crucial component of each disorder is
lacking: treatment options. This literature review will
discuss that missing component for two disorders:
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If criteria for both disorders are met, only the CD
diagnosis is given. ADHD and CD are different in
that those with both CD and ADHD may be
impulsive, hyperactive, and disruptive, but those with
only ADM) do not typically violate age-appropriate
norms like those with CD. When criteria for both of
these disorders are met, both diagnoses are given
(DSM-IV-TR, 2000).
Antisocial Personality Disorder, with which many
people with child-onset Conduct Disorder are later
diagnosed, is a serious and rarely diagnosed
personality disorder. The main characteristic ofthis
disorder is a pervasive pattern of disregard for and
violation of the rights of others. This behavior begins
in childhood or adolescence, and follows the person
into adulthood. The two other criteria for the
diagnosis of this disorder are that the person must be
at least 18 years of age to be diagnosed and he or
she has to have shown some symptoms of CD
before age 15. The four behavioral categories that
apply to a CD diagnosis, as described above, also
apply to that of an APD diagnosis (DSM-IV-TR,
2000). People with APD tend to be irresponsible
and highly critical of others, while they are generally
non-remorseful for wrongdoings that they commit.
Some other associated features of the disorder are
impulsivity, cockiness, superficial charm, and
promiscuity. People with this disorder oftentimes
meet the criteria for other Personality Disorders such
as Borderline, Histrionic, and Narcissistic
Personality Disorders. They also have a high
likelihood of being diagnosed with Anxiety
Disorders, Substance-Related Disorders, and
Depressive Disorders. The prevalence of this
disorder is approximately 3% in males and 1% in
females, but the disorder has been shown to lessen
in symptomology as the diagnosed individuals grow
older, with a noticeable reduction specifically by
their fourth decades (DSM-IV-TR, 2000).
In cases ofthe APD diagnosis, it can be difficult
to discern this disorder from other Personality
Disorders. People with both APD and Borderline
Personality Disorder display manipulation, but the
difference lies in their motives. People with APD are
manipulative for power, money, or other material
objects, whereas people with Borderline Personality
Disorder are manipulative to gain attention and

discussed in terms of the aforementioned categories
taken from the DSM-IV TR.
CD is a Disruptive Behavioral Disorder that has
three main diagnostic criteria. Criteria A is that the
person in question repetitively behaves in a way that
violates the basic rights of others or age-appropriate
societal norms. These violations are separated into
four groups: aggression that causes harm to or
threatens other people or animals, nonagressive
behavior that results in property loss or damage,
deceitfulness or theft, and serious rule violations. In
order to be diagnosed with CD, three or more of
these characteristics must have been present within
the last year, with one of the characteristics present
within the last 6 months (DSM-IV-TR, 2000).
Criteria B states that the person exhibits
disturbances in behavior that lead to significant
impairments in his or her academic, social, or
occupational functioning. Criteria C clarifies that a
person may be diagnosed with CD after age 18, but
only if a diagnosis ofAPD cannot be given. There
are two onset types of CD: Childhood-onset and
adolescent-onset. The main differences between the
two onset types are that the childhood-onset type is
diagnosed before age 10, whereas the adolescentonset type is diagnosed after that age, and those in
the childhood-onset group are usually male, show
more aggression, and are more likely to develop
APD later in life as compared to older onset group
(DSM-IV-TR, 2000).
In terms of associated features, the DSM-IV-TR
(2000) indicates that those with CD typically lack
empathy or concern for others, and often
erroneously view the intentions of others as
malicious. Also, these people may be more likely to
take part in risky behavior, such as engaging in
sexual behavior at a young age, drinking, and using
illegal substances. Oftentimes, those with CD are
found to have Attention-Deficit/Hyperactivity
Disorder (ADHD), or other Learning, Anxiety, or
Mood Disorders (DSM-IV-TR, 2000). In
examining general population studies, prevalence
rates range from 1 to 10%, with the disorder being
more widespread among males. This disorder is
distinguished from Oppositional Defiant Disorder
(ODD) by the persistent violation of ageappropriate societal norms and the rights of others.
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nurturance. Additionally, people with APD show
more aggression and emotional instability than
people with Borderline Personality Disorder. People
with both an APD diagnosis and a Histrionic
Personality Disorder diagnosis tend to be impulsive,
superficial, reckless, and manipulative, whereas
people with only Histrionic Personality Disorder do
not generally exhibit antisocial behavior. Lastly,
people with both APD and Narcissistic Personality
Disorder are stubborn, superficial, and
unempathetic. The difference between the two
disorders is that those with only Narcissistic
Personality Disorder are not impulsive, aggressive,
or deceitful, but they are needier ofthe attention of
others than those with APD (DSM-IV-TR, 2000).
The fact that CD and APD share many of their
symptoms suggests that they are very similar
disorders. However, a review of the literature on the
treatments of each of these disorders suggests that
they have one major difference. The difference that
becomes evident is that there are many more
treatment options for CD than there are for APD,
suggesting that it is much easier to treat the
symptoms when they first surface, during the early
stages of CD. This literature review focuses on
examining both medicinal and therapeutic treatments
for CD and APD. Medicinal approaches in treating
CD that will be discussed are lithium,
methylphenidate, and risperidone. These
medications are not used to treat CD in its entirety,
since it is so pervasive in nature, but instead are used
for curtailing specific symptoms of CD. Therapy,
however, does consider CD as a whole disorder,
and works to improve all problematic elements
within the disorder. This literature review will discuss
parent management training and cognitive-behavioral
therapy as two therapeutic options for CD. For
APD treatments, the scope of previously conducted
research is narrower, but medicinal options such as
risperidone and quetiapine will be discussed as
thoroughly as possible, as well as residential
treatment facilities as a therapeutic treatment
technique.
In considering CD and APD, especially in terms
of their prevalence rates being so low, one may
wonder why this area of psychology deserves
immediate attention. It must be recognized though

that APD, in addition to being a serious personality
disorder, is also considered an equally serious social
threat. Within prison settings, up to 75% of inmates
are likely to meet an APD diagnosis, which holds the
harrowing implication that people with APD are at
high risk of committing serious criminal offenses
(Hare, 1996 as cited in Reid, & Gacono, 2000).
They are estimated to be responsible for over 50%
of the serious crimes committed, and a 1992 study
by the FBI found that 44% of the people
responsible for killing an officer on duty had APD
(Walker, Thomas, & Allen, 2003). These statistics
paint a more powerful picture than the low
prevalence rates ofAPD do, and illustrate the
importance of treating CD before it evolves into an
APD diagnosis.

Conduct Disorder
Medicinal Treatments for Specific Isolated
Symptoms of CD
Lithium in treating aggression. Since CD has a
wide range of symptoms, treatment providers often
aim to reduce or eliminate the most severe
symptoms first. One of these targeted symptoms is
maladaptive aggression, which is considered serious
in that it usually leads to some personal loss ofthe
patient, the patient's family, and/or society (Steiner,
Saxena, & Chang, 2003). Usually, pharmacologic
treatment is given to CD patients only in cases when
this type of overt aggression is the chief symptom of
their disorder (Gerardin, Cohen, Mazet, & Flament,
2002). Since aggression is considered a normal and
useful survival tool, physicians never aim to eliminate
this characteristic in their patients. Instead, they
attempt to shape it into a more adaptive
characteristic. Because ofthe separation that exists
between maladaptive and adaptive aggression, any
aggression that a person with CD exhibits must be
viewed in its context. An example of maladaptive
aggression would be if a child walked over to
another child unknown to him or her, and punched
him or her in the face. This is maladaptive because
the victimized child did nothing to elicit the abuse
that he or she endured. An example of adaptive
aggression would be if a child punched a perpetrator
who was attempting to hurt his or her sibling. The
5

Methylphenidate in treating aggression and
impulsivity. Methylphenidate (MPH), a
psychostimulant, has also been tested as a possible
CD-symptom reliever. There is a long history of
psychostimulant use in the treatment of behavioral
disorders. It is likely that research will continue in
this area and that psychostimulants will remain the
first choice of physicians in the treatment of CD
(Mpofu, 2002). Klein et al. (1997, as cited in
Shreeram & Kruesi, 2000) studied the effects of
MPH on 84 children with CD and found that the
medication group was superior to the placebo group
in minimizing CD symptom ratings. Kaplan et al.
(1990, as cited in Shreeram & Kruesi, 2000)
studied the effects of MPH on male conductdisordered adolescents, and found that it significantly
reduced physical aggression in the subjects. In
addition to decreasing aggression, Connor, Barkley,
and Davis (2000) found that their subjects
responded less impulsively to certain tasks after
being treated with MPH, though no placebo
comparison was made in this study. Furthermore,
these researchers found that MPH usage decreased
CD-symptom severity, as measured before and after
treatment on the Disruptive Behavior Scale (DBS).
Contradicting these positive results though are
results from studies like that of Pelham et al. (1991,
as cited in Shreeram and Kruesi, 2000), in which
researchers found a response rate of only 50% to
MPH.
Risperidone in treating aggression and
impulsivity. Another medication frequently used to
decrease aggression in CD patients is risperidone,
an atypical antipsychotic (Findling, McNamara,
Branicky, Schluchter, Lemon, & Blumer, 2000).
This medication is unique in that many older children
and adolescents who exhibit aggression and have
not responded to other medications have responded
to risperidone (Fras & Major, 1995; Schreier,
1998, as cited in Shreeram & Kruesi, 2000). Ercan,
Kutlu, Cikoglu, Veznedaroglu, Erermis, and Varan
(2003) and Findling et al. (2000) found that even
with small doses of risperidone (as little as .25 mg/
day), aggression in children and adolescents with
CD was decreased. Ercan et al.'s (2003) study is
especially notable in that the researchers included
only subjects who were considered to have severe

child's reaction would then be seen as adaptive
because it is a protective mechanism (Steiner,
Saxena, & Chang, 2003).
One pharmacologic treatment that has been
repeatedly tested to combat maladaptive
aggressiveness in children and adolescents with CD
is lithium carbonate (Malone, Delaney, Luebbert,
Cater, & Campbell, 2000), which is a mood
stabilizer used to control aggression in manicdepressive patients (Gerardin et al., 2002). Although
there is no licensed drug for treating CD, lithium is
the most documented drug treatment for the
disorder (Gerardin et al., 2002). Lithium was found,
by Malone et al. (2000) to be a safe and effectual
short-term treatment for aggression in children and
adolescents with CD diagnoses. In this study, the
Overt Aggression Scale (OAS) was used to
measure aggression before and after lithium
administration. Using this scale as a measurement
tool, the researchers discovered that there was a
statistically significant reduction in overt aggressive
behavior of those with CD who received 4-weeks
of lithium treatment in comparison to those who
received the placebo. Sixteen of the 20 lithium
recipients responded positively to lithium, whereas
only 6 of the 20 placebo recipients responded
positively to their treatment (Malone et al., 2000).
Although some studies conducted on lithium
effectiveness show a decrease in subject aggression,
many other studies show no such result. In studies
by Carlson, Rapport, Patakai, and Kelly (1992),
Klein (1991b), and Rifkin et al. (1997), no
significant difference was found between subjects
who were given lithium versus those who were given
the placebo (Mpofu, 2002). Some possible
explanations for these contradictions, aside from
lithium producing inconsistent results, are that the
samples from each of these studies drastically
differed in terms of ages of the subjects and the type
of patient being treated (inpatient vs. outpatient)
(Mpofu, 2002). Additionally, the sample size of
many of the lithium studies was too small for their
results to be generalized (Weller, Rowan, Weller, &
Elia, 1999). Researchers have generally accepted
the idea that the usefulness of lithium in treating
aggression is in need of further testing (Mpofu,
2002).
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CD, which was determined by high scores on both
the aggression and delinquency subscales ofthe
Child Behavior Checklist (CBCL). In this study,
improvement in subjects was measured using the
Clinical Global Impression (CGI) scale, which
ranges from 1 to 7, 7 demonstrating the most severe
manifestation of CD symptoms. At the start of the
study, the mean CGI rating for the sample of21
children and adolescents was 6.4. After 8 weeks of
risperidone treatment, this rating shifted to a 3.2.
The symptom of CD that seemed to decrease most
in this study was aggression, but there were also
significant decreases found in the impulsivity of the
subjects (Ercan et al., 2003). Findling et al. (2000)
compared their medication group to a placebo
group, and found that the treatment group showed
improvements on nearly all measures of aggressive
behavior, whereas the placebo group failed to
demonstrate such improvements. Although these
studies seem to suggest that risperidone may be an
effective treatment for aggression and other CD
symptoms, limitations like subject attrition (Findling
et al., 2000), and lack of double-blind placebocontrolled designs (Ercan et al., 2003) still leave
questions about the effectiveness of risperidone.
Dangers of medicinally treating CD
symptoms. Even if a medication is deemed in the
future as a successful treatment for CD symptoms, it
is necessary to weigh the medication's consequences
against its actual benefits. Forming the bulk of these
consequences are the side effects of the medication.
Even the medications currently being tested for their
effectiveness in treating CD symptoms have a list of
side effects attached to them. Lithium, for instance,
although seemingly helpful in reducing aggression in
some CD patients, has been known to produce
cognitive dulling, weight gain, enuresis (Weller et al.,
1999), sedation, fine tremor, hypothyroidism, and
leukocytosis (Mpofu, 2002). Psychostimulants, like
methylphenidate, have side effects like loss of
appetite, insomnia, nervousness, abdominal pain
(Shreeram, & Kruesi, 2000), dependency, social
withdrawal, and psychosis (Mpofu, 2002). With
risperidone and other antipsychotic medications,
side effects such as weight gain, sedation, anxiety
(Shreeram, & Kruesi, 2000), and orthostatic
hypotension (Mpofu, 2002) have been noted. Even

potentially fatal side effects, such as fluctuating vital
signs and neuroleptic malignant syndrome have been
associated with antipsychotic use in the pediatric age
group (Shreeram, & Kruesi, 2000). Because of the
gravity of some of these side effects, physicians may
want to reconsider using medication for CD unless
they feel confident that the benefits will outweigh the
negative effects.
Therapeutic Treatments for Conduct Disorder
Parent management training. Parent
management training (PMT) is the most thoroughly
investigated therapeutic technique for children and
adolescents with CD (Kazdin, 2003). Behavioral
methods, such as PMT, have been researched
extensively over the last 30 years, and this research
history has resulted in many clinicians' respect for
these techniques (Hutchings, Lane, & Kelly, 2004).
Many support this type of therapy because there is a
belief that aggression and other behavioral problems
are developed and inadvertently reinforced in the
home by maladaptive interactions between parents
and their children (Kazdin, 2003). This belief is
supported by research that has highlighted parenting
variables as factors linked with antisocial behavior
early in life, as well as subsequent delinquency
(Campbell, 1995; Loeber & Jay, 1994; Patterson,
Reid, & Dishion, 1993; Reid, 1993, as cited in
Hutchings, et al., 2004). Therefore, PMT has been
designed to make parent-child interactions more
positive.
PMT has been studied in connection with
children and adolescents ranging from ages 2 to 17,
and these studies have included a wide range of
conduct problem severity within their subjects
(Kazdin, 2003). One subtype of PMT, known as
Parent-child interaction therapy (PCIT) has been
tested on children as young as preschoolers who
display early behavioral problems (Nixon, Sweeney,
Erickson, & Touyz, 2004). PCIT is based on Hanf's
(1969) model of parent-training (as cited in
Sheldrick, Kendall, & Heimberg, 2001) and was
designed to teach parents how to play positively
with their children and interact with them in a way
that will modify unwanted behavior. It also presents
parents with precise behavior management
strategies, such as clarifying instructions to their
children, and punishing them appropriately for their
7

misbehavior (Nixon et al., 2004). Nixon et al.
(2004) found that PCIT was more effective than
non-treatment in improving the behavior of conductdisordered preschoolers, and that this positive effect
could still be seen in most of the children two years
after the therapy ended. This study differs from other
studies conducted on PCIT because it followed the
subjects for a considerable amount of time after
therapy, whereas other studies have only illustrated
the short-term benefits of PCIT (Eyberg et al.,
2001; Funderburk et al., 1998, as cited in Nixon et
al., 2004). However, Nixon et al. (2004) failed to
include a comparison group in their follow-up
measurements, so it is unclear ifthe lasting behavior
improvements were due to the treatment, or to
another factor, such as subject maturation (Nixon et
al., 2004).
PMT, in comparison to PCIT, is a more
structured and comprehensive type of instructional
therapy. It is based on the social learning theory, and
integrates the concepts of time-out, positive
reinforcement, and contingency contracting into
treatment (Kaalin, 1993 as cited in Hutchings et al.,
2004). Explicit booklets have even been developed
describing how to implement PMT for different age
groups. The skills taught in this type of therapy can
reach parents through a variety of mediums: through
the therapist meeting with one or both parents, or
through the therapist providing the parent(s) with
informational videos (Frick, 2001). Although each of
these variations has been shown in different studies
to have a positive effect on conduct-disordered
children, meeting with both parents seems to be
most effective (Webster-Stratton, & Hammond,
1997; Webster-Stratton et al., 1988, 1989 as cited
in Farmer, Compton, Burns, & Robertson, 2002).
The informational video option provides an
alternative for parents who cannot afford many
therapy sessions. Research on these videos indicates
that they can be effective in behavior control of
children, however they do not seem to be as helpful
as face-to-face meetings between the parents and
the therapist (Farmer et al., 2002).
PMT is based around the idea that parenting
styles that include nagging, inconsistent discipline,
ineffective punishments, and minimal positive
parental involvement play a significant role in the

development and maintenance of childhood
behavioral problems. The PMT design specifically
targets these characteristics within parent-child
interactions and attempts to obliterate them and
replace them with more effective approaches
(Hutchings et al., 2004). In the office, PMT
combines sessions where the therapist meets with
the parent(s) alone to teach them various parenting
skills with sessions where the child is present for the
parent(s) to practice their learned techniques on.
PMT sessions teach parents about different stages
of child development and how they should treat their
children during each stage to assist them in
developing a positive social-emotional identity
(Mabe, 2003). Therapists teach parents how to
extinguish any antisocial characteristics their children
may exhibit, and how to replace these characteristics
with prosocial ones through positive reinforcement.
Parents are advised on how to structure their
interactions with their children by setting limits,
responding appropriately to their children's' negative
emotions, and communicating their requests to their
children effectively (Mabe, 2003). Also, parents
learn what types of disciplinary action work best in
behavior control, and how to time their discipline to
make it more successful. This forces parents to see
their children's behavior in a broader context, and
provides a practical conceptualization of what effect
the familial environment can have on a child's
behavior (Frick, 2001). By adopting this socialecological stance on behavior, parents begin to
recognize that many factors and systems (like the
child's home and school system) come together to
influence their child's behavior. Recognizing this can
help parents see the need for their inclusion in their
child's treatment (Borduin, 1999).
Hutchings et al. (2004) conducted a four-year
follow-up study comparing two types of PMT for
41 2-10 year-olds. One type was a standard form
of PMT, while the other was an intensive form. The
intensive form differed from the standard in that it
lasted for 25 hours instead of only 7 hours, and it
gave parents a chance within therapy to practice
what they were being taught, and directly experience
the success of their newly acquired skills. This study
found that both forms of PMT were successful in
reducing conduct problems in the children, but that
8

important benefits. First, group meetings are more
economical than individual meetings for clients.
Second, group-based skills training has been shown
in numerous studies (Cavell, & Hughes, 2000;
Beelman et al., 1994; Kavale, Mathur, Forness,
Rutherford, & Quinn, 1997; Schneider, 1992, as
cited in Ang, & Hughes, 2002) to produce larger
benefits than individual-based skills training.
Something interesting to note about this group setting
though is that in many of these studies, it was found
that conduct-disordered children improve more
behaviorally when they are mixed in groups with
children who do not have CD, instead of being
treated in a group consisting only of children with
CD or antisocial behavior (Ang, & Hughes, 2002).
Therapists administering CBT play a very active
role in the treatment process by modeling the skills
they are teaching, providing prompts for certain
behaviors, role-playing with the children, and
providing feedback and praise when the children use
skills appropriately (Frick, 2001). Many CBT group
programs also incorporate a token economy into
their treatment plan, because it fits with the theme of
operant conditioning and has also shown signs of
being effective in improving the behavior of nonresponsive youth with CD (Field, Nash, Handwerk,
& Friman, 2004). In CBT, therapists attempt to
convey genuineness to their clients, so their clients
will trust them, hopefully leading to them being less
resistant to change. Also, anger management and
emotion control are two topics that are extensively
addressed within therapy (Broota, & Sehgal, 2004).
Broota and Sehgal (2004) performed a study
including 80 children with discipline and conduct
problems where they compared results from four
treatment groups: CBT treatment only, parental
counseling only, CBT plus parental counseling, and
unrelated conversation only (the control group). Preand post-treatment, they took measurements of
factors such as childhood psychopathology, anger
expression, and parental discipline, and across all of
their measurements, there was a significant positive
change in all three of the treatment groups. Although
they found CBT to be an effective treatment in
comparison to the control group, the treatment that
yielded the best results was CBT plus parental
counseling, suggesting that the solution to treating

the intensive form elicited a more significant and
lasting change. This adds to the evidence base that
therapy involving parental training and rehearsal of
child-management techniques has a better outcome
than more didactic and less interactional types of
therapy, where parents do not experience as much
collaboration with the therapists. Also, the
researchers found that the therapy administered in
this study had a more noticeable effect in the
younger children, suggesting that the earlier the
intervention, the more successful it is (Hutchings et
al., 2004).
Cognitive-behavioral therapy. Another therapy
used for treating CD is cognitive-behavioral therapy
(CBT), a form developed by Beck et al. (1979) and
Ellis (1962) (both cited in Broota, & Sehgal, 2004).
Since CD falls under the umbrella of Disruptive
Behavioral Disorders, CBT aims to help clients
control their behavior by becoming aware of their
thought processes before reacting to situational cues.
Studies on the perceptions of conduct-disordered
children show that these children differ from children
without CD in the way that they interpret their
environments (Van de Weil et al., 2002). Conductdisordered children are more likely to selectively
direct their attention towards hostile social cues,
therefore heightening the likelihood that they will
respond in an aggressive manner to their
environments (Van de Weil et al., 2002). Even in
ambiguous situations, children with CD tend to
interpret situations as threatening to them, showing a
deficit in their social cognition (Frick, 2001). They
are also less likely than children without CD to
spawn solutions to social problems (Van de Weil et
al., 2002).
CBT is designed to lead children through
exercises that encourage them to encode and
interpret all situational cues, and to formulate and act
upon situation-appropriate goals (Van de Weil et al.,
2002). CBT, like PMT, uses a skills-building
approach, but CBT works predominantly with
children as opposed to parents. Moreover, most
CBT programs are designed to accommodate
clients in group settings (Frick, 2001). Although
children do not get as much individual attention when
combined with other children, group-based skills
training sessions such as these have at least two
9

CD may lie in attacking it from all different angles at
once (Broota, and Sehgal, 2004). Rohde, Clarke,
Mace, Jorgensen, and Seeley (2004) did not find
CBT to have such a positive effect on CD in their 93
adolescent subjects though. They studied CBT in
relation to adolescents who were diagnosed with
comorbid Major Depressive Disorder (MDD) and
CD, and found that the therapy reduced MDD
symptoms, but did not have an effect on the course
of CD during or post-treatment. One possible
explanation for this is that the form of CBT
administered to the subjects was tailored in some
ways to reducing MDD symptoms, so this may have
taken away from any treatment components that
could have positively affected CD symptoms
(Rohde et al., 2004).
Limitations to CD therapy and research on
therapeutic treatment. The most common therapyrelated problem is that between 40-60% of people
who begin therapy do not complete treatment
(Wierzbicki & Pekarik, 1993 as cited in Kazdin,
2003). Despite therapists' best efforts to make
sessions as engaging as they can for parents, client
drop-out rates are an especially prevalent problem
with PMT treatment (Frick, 2001). Miller and Prinz
(2003) specifically set out to study engagement of
families in the treatment of childhood conduct
disorders, and identified different possibilities for
why parents may truncate PMT treatment. They
found that families that completed treatment were
more likely to have approached treatment with
internal expectations, believing that treatment would
address issues within the family, such as parenting
style. In contrast, those parents who dropped out of
treatment were more likely to have demonstrated
external expectations of treatment, believing that the
treatment would focus more on the child and his or
her behavior. These latter parents may have felt that
treatment was not focusing enough on what they
considered to be the root of the problem, or in other
words, their child's behavior. This idea implies that
therapy style is not the only factor that influences
treatment outcome. Also important are the attitudes,
attributional styles, and motivations ofthe parents
involved (Miller, & Prinz, 2003).
Another problem with the research on PMT
effectiveness is that although it seems beneficial, it
10

has not been studied in direct comparison to other
therapies. Therefore, researchers and clinicians have
failed to determine if PMT is superior to other forms
of therapy used to treat CD (Van de Wiel, Matthys,
Cohen-Kettenis, & Van Engeland, 2002). Although
PMT has supportive research results on its side,
something to consider is that researchers and
therapists have yet to fully understand the mediating
factors for its success, which does not bode well for
improving what is already being practiced
(Remshmidt, 2003). Another barrier to PMT
treatment was identified in a study conducted by
Kazdin and Wassell (1999). These researchers
considered demographic factors that may play a role
in how receptive children are to PMT treatment, and
found that socioeconomic disadvantage, parental
stress, and parental psychopathology predicted
inferior treatment outcomes (Kazdin, & Wassell,
1999). This shows that factors external to treatment
may also have to be addressed within treatment for
any type of behavior resolution to be reached.
In terms of CBT research, most studies
addressing this issue lack follow-up measurements,
so the long-term effect of this treatment type remains
undetermined. Also, CBT seems to work best with
older children and adolescents than with younger
children, perhaps indicating that a person may need
to be at a certain stage in his or her cognitive
development before being exposed to CBT (Van de
Weil et al., 2002). Many times therapists encounter
difficulty in getting their clients to practice the skills
they are taught outside of treatment, in their normal
environments, which may negatively impact the
endurance of this treatment (Frick, 2001).

Antisocial Personality Disorder
Medicinal treatment for specific isolated
symptoms of Antisocial Personality Disorder
Since APD is a personality disorder, and
personality is a relatively stable characteristic, there
is not much evidence that medicine helps in treating
the disorder. Because of the low prevalence of
APD, most published research on medicinal
treatments for the disorder has been in the form of
case studies. One very successful case study
conducted by Hirose (2001) focused on a 32-year-

old man who was hospitalized for severe APD. After
receiving 3 mg/day of risperidone, he experienced a
noticeable reduction in aggression and impulsivity,
and for the first time in his life, was able to maintain a
job (Markovitz, 2004). These results cannot be
generalized though because only one person was
treated, and treatment success of this kind is very
rare with APD. Walker, Thomas, and Allen (2003)
studied the effect that quetiapine, an atypical
antipsychotic, would have on treating impulsivity,
aggressiveness, and irritability inAPD patients. They
found that quetiapine was successful in reducing
these characteristics in the APD patients, and it did
so with very few side-effects. However, this study
only included 4 subjects and long-term effects were
not measured, which limits the reliability ofthe
results. Additionally, even if quetiapine is labeled in
the future as an empirically supported treatment for
APD, very few treatment facilities (especially prisons
and jails, where most people with APD are treated)
will have the funds necessary to dispense this
treatment (Walker, Thomas, & Allen, 2003).
An issue that often arises while attempting to
medicinally treat APD is that many patients with an
APD diagnosis are drug-seeking, and have a history
of drug abuse. This poses a problem because they
tend to reject drugs that do not produce a euphoric
effect, and often seek out drugs that they have been
addicted to in the past, instead of ones that actually
help any APD symptoms they are exhibiting
(Walker, Thomas, & Allen, 2003).
Residential Treatments of Antisocial Behavior
and Antisocial Personality Disorder as a Whole
Although APD is defined in the above
introduction, it is important also to define antisocial
behavior more generally. In providing this definition,
we are recognizing that a person who demonstrates
antisocial behavior does not always go on to
demonstrate all criteria necessary to meet an APD
diagnosis. Antisocial behavior can most simply be
defined as behavior that lacks empathy or regard for
others, as well as a distinct inability to adjust to
behavioral norms and expectations, which are
usually standardized by society (Frankfort-Howard,
& Romm, 2002). To help clarify the distinction
between antisocial behavior andAPD, antisocial
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behavior can be viewed as a symptom of both CD
andAPD, but even if a child or adolescent with CD
displays antisocial behavior, he or she cannot be
diagnosed with APD until after age 18. Additionally,
antisocial behavior, as defined above, is only one of
the many diagnostic criteria for APD (DSM-IV TR,
2000).
For those children who display antisocial
behavior and are left untreated, the risk of being
diagnosed later in life with APD is rather high. It is
estimated that 40 to 50% of these children will go on
to become antisocial adults (Robins, 1966, as cited
by Frankfort-Howard, & Romm, 2002). This
statistic implies that antisocial behavior is an urgent
social issue, yet there are very few noteworthy
solutions to this problem (Wong, 1999). To reduce
these numbers of what Caspi and Moffitt (1995, as
cited in Frankfort-Howard, & Romm, 2002) refer
to as "life course persistent" cases of antisocial
behavior, residential treatment programs are
oftentimes recommended, or in criminal cases,
required by law. Many clinicians believe that this
type of environment provides the secure and
controlled atmosphere necessary to facilitate
behavioral change (Wong, 1999). These programs
are specifically designed to target the pervasive
nature of antisocial behavior, and may include
components such as school courses, occupational
training, and social skills assistance. In addition to
these offerings, residential treatment facilities usually
include some combination oftherapeutic activities,
such as individual or group counseling, family
counseling, community meetings, cognitive and
behavioral programs, volunteer activities, and
tutoring (Frankfort-Howard, & Romm, 2002).
These programs, which are often referred to as
multisystemic or multiple system therapy (MST)
programs, have been reported by many clinicians as
the most successful preventative treatment options
for APD (Reid, & Gacono, 2000). Unfortunately,
although deemed "most successful," these programs
often prove too costly for the modest benefits they
produce (Wong, 1999).
Although many residential programs have been
designed to decrease the prevalence of life persistent
antisocial behavior and APD, research about their
effectiveness is limited. One reason for this limited

treatment programs. It was also discovered that
scope is that a longitudinal study, the type of study
82% of these boys needed special education
that would most clearly and thoroughly illustrate the
effects of residential treatment centers, is very costly services post-treatment, as well as 57% of them
needing out-patient therapy. These results suggest
and funding is lacking for well-designed studies of
this type. In addition to this, many ofthe studies that that delinquent and antisocial young people show a
need for long-term treatment options in order to
have been conducted are flawed by methodological
decrease recidivism and continuation of maladaptive
problems including nonexistent control groups to
compare results to, debatable rater subjectivity, and behaviors (Frankfort-Howard, & Romm, 2002).
Generally, the most optimistic research suggests
differences in outcome definition and measurement
that inpatient programs that treat young antisocial
(Curry, 1991 as cited in Frankfort-Howard, &
offenders for a year or longer are more effective
Romm, 2002). Many studies also include a sample
than ones attempting to treat antisocial adult
size too small to generalize the results found
offenders (Reid, & Gacono, 2000). However,
(Messina, Wish, Hoffman, & Nemes, 2002). There
Kazdin's 1989 study (as cited in Wong, 1999)
have also been problems in understanding and
replicating components within treatment facilities that reported optimistic findings after just 2 to 3 months
of inpatient psychiatric care. Using behavior
may be useful, because many studies that focus on
checklists and clinical inventories before treatment
treatment outcome fail to provide in-depth
descriptions of treatment procedures and client
and comparing them to the same measurements one
characteristics (Wong, 1999). These issues make it
month, one year, and two years after the treatment,
Kazdin found that there were statistically significant
difficult to move forward in terms of improving
improvements on nearly all ofthe clinical measures,
treatment, because there is such little evidence of
what has worked in the past, and if any evidence of especially measures that indicated reductions in
aggressive and hostile behavior (Wong, 1999).
that sort does exist, it is difficult to determine why
While treatment options for antisocial behavior
those certain treatments were effective.
Research results in this area vary, but much of
on its own appear to lack consistency and promise,
options forAPD are even less encouraging. Most
what has been found does not allude to promising
treatment designed to target this disorder focus on
outcomes for children who display antisocial
behavior. For example, Knapp, Schwartz, and
specific behaviors ofthe disorder, instead ofthe
Epstein (1994, as cited in Frankfort-Howard, &
disorder as a whole. Some such behaviors include
Romm, 2002) conducted a five-year longitudinal
substance abuse and violence (Reid, & Gacono,
study on male delinquents that had been released
2000). Long-term correctional settings seem to have
from a Michigan residential treatment program. They little effect on symptoms ofAPD that are
found that 20% ofthe sample was sentenced to
characterologically based, but they do seem to
reduce criminal recidivism and drug abuse, which
adult prisons, the majority ofthis group being
imprisoned within three years of their release from
are two symptoms frequently observed in people
with APD (Reid, & Gacono, 2000). Many studies
treatment. Amore descriptive study (Asarnow,
Aoki, & Eslon, 1996, as cited in Frankfort-Howard, focused on the reduction of such APD symptoms
& Romm, 2002) focused for four years on 51 boys found that treatment completion in residential settings
was the highest predictor of reduced drug use and
who had previously been released from residential
post-treatment arrests (Messina, Wish, Hoffman, &
treatment programs. This study was aimed at
Nemes, 2002; DeLeon, 2000, as cited in Messina
determining the likelihood ofthese boys being
admitted to another treatment facility after being
et al., 2002). From these studies, and other
residential treatment studies, it is unclear what factor
released from their previous one. In this study,
researchers found that 32% of this group was at risk within the treatment completion influences outcome
the most though. Some factors to consider are
for out-of-home treatment by the end of their first
year, 53% by the end of their second year, and 59% patient compliance and the dose of each specific
by the end of their third year out of their residential
service received within the therapeutic community
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(Messina, Wish, Hoffman, & Nemes, 2002). The
most successful programs seem to combine
consistent clinical and correctional techniques, and
pattern their systems around a hierarchical privilege
system, intolerance for rule breaking, and a strict
encouragement to complete the program regardless
of the length of the patients' sentence (Reid, 1981;
Reid & Burke, 1989 as cited in Reid & Gacono,
2000).
At the time of their research, Reid and Gacono
(2000) found only one study that illustrated any real
success with treating adults with APD in a residential
setting. This study, organized by Messina et al.
(1999), reported that substance abusers with APD
responded well to both standard and abbreviated
residential treatments. Their success was measured
by the reduction in their drug abuse and recidivism
rates, but follow-up in this study was limited (Reid,
& Gacono, 2000).
Although this lack of hopeful research makes it
easy to jump to the conclusion that people with APD
are untreatable, it is necessary to look at other
factors that may be influencing treatment outcome.
For example, many studies report that the people
being observed left treatment prematurely, which
could have easily impacted their outcome negatively
(Reid, & Gacono, 2000). It is also important to note
that there is a general consensus among social
scientists and treatment providers that the nature of
APD makes it unlikely that anyone with the disorder
will change their behavior (Messina, Wish, Hoffman,
and Nemes, 2002). This pessimism amongst
especially treatment providers could account for the
treatment options already in effect not being
successful. If treatment facilitators are going into
their jobs with defeatist attitudes ofthe sort,
treatment could be negatively affected.
From the research reviewed, it seems that it is
more likely to witness behavior change when
antisocial behavior is treated in children and
adolescents than when it is treated as a symptom of
APD later in life. While treating APD, some
evidence exists that certain symptoms, such as drug
abuse and criminal behavior can be reduced, but the
disorder as a whole appears unshakable.
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Future Research and Conclusions
In reviewing the evidence for and against
different treatments for CD and APD, two ideas
become obvious. The first idea is that all treatments
that have been tested have produced mixed results,
and because ofthis lack of consistent support, no
one treatment can be accepted by clinicians and
physicians. The second idea is that out of the
treatments that have been tested, more promising
results have surfaced for the treatment of CD,
indicating that it is an easier disorder than APD to
combat, and that early intervention should be a goal
of physicians and clinicians handling children and
adolescents with CD. In conclusion, research should
be continued in the area of treating CD and APD,
with a special focus on intervention to prevent APD
from developing later in life. For those who already
have an APD diagnosis, research should be
continued regarding the use of psychotherapy for
treatment, since this type ofresearch is still in its
beginning phases (Kopta, Lueger, Saunders, &
Howard, 1999).
An issue to consider in future research designs is
the fact that CD is so frequently comorbid with other
disorders. Research shows that in most cases,
treatment specificity is needed in cases where
comorbidity exists, and that perhaps specific
treatment programs for different disorders should be
created (Rohde et al., 2004). Even in cases where
comorbidity is not present, children and adolescents
with CD respond so differently to treatment options
that it may be necessary for psychotherapists to
design treatment programs on a case-by-case basis,
which is problematic because within their training,
there is a push towards standardized treatment
(Chambless, & 011endick, 2001). In regards to
treating APD, society should first work to obliterate
the negative connotation that is attached to the
disorder. People with this disorder are often viewed
as "morally deranged," and by labeling them as so,
we are perhaps implying that their immorality makes
them undeserving oftreatment. It is possible that this
perspective may be blocking us from taking steps
forward in identifying an effective treatment for APD
(Smith, 1999). Since it is estimated that so many
crimes are committed by people with APD, the
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